Search

MR imaging is useful in differentiating and characterizing renal masses. A careful evaluation of the signal characteristics and morphology of a renal mass combined with the ancillary imaging findings and patient history should assist the radiologist in making the proper diagnosis or recommending the appropriate treatment in most cases. This pictorial essay demonstrates the typical MR imaging features of common renal masses including renal cell carcinoma (RCC), oncocytoma, angiomyolipoma, metastases, transitional cell carcinoma (TCC), lymphoma, and arteriovenous malformation (AVM), and highlights several potential diagnostic pitfalls in making the proper diagnosis.

Purpose: It has been proposed that there is an increased frequency of pancreatic abnormalities in patients with primary sclerosing cholangitis (PSC). Our purpose is to compare the frequency of pancreatic abnormalities detected at MRI in patients with PSC and to compare these findings with those found in a matched cohort with other liver diseases., Method: We identified 29 patients who had either a histologic or an endoscopic retrograde cholangiopancreatography diagnosis of PSC and 29 age- and gender-matched patients with liver disease without PSC who underwent MRI at 1.5 T. The protocol included breath-hold T1-weighted gradient echo, echo train, fast spin echo, T2-weighted images and dynamic gadolinium-enhanced MRI. Two blinded readers retrospectively evaluated the MR images for abnormalities of pancreatic size and morphology, T1 and T2 signal intensity, duct size and irregularities, arterial-phase contrast enhancement, focal pancreatic masses, cystic lesions, peripancreatic fluid/edema, ascites, and capsular-like rim surrounding the pancreas., Results: The prevalence of pancreatic and peripancreatic abnormalities was 10 of 29 (35%) in PSC patients and 14 of 29 (48%) in control patients. MR findings included ascites (9 PSC, 12 controls), peripancreatic edema (7 PSC, 11 controls), atrophy (4 PSC, 3 control), increased T2 signal (3 PSC, 4 controls), cystic lesions (2 PSC, 3 controls), abnormal T1 signal (1 PSC, 2 controls), and dilated pancreatic ducts (3 PSC, 2 controls). Quantitative parameters were not significantly different between PSC patients and the control subjects with pancreatic findings., Conclusion: There is no significant difference in pancreatic abnormalities detected on MRI between patients with PSC and those with other liver diseases.

The authors describe two cases of penetrating ulcers of the descending thoracic aorta associated with intramural hematoma of the ascending aorta. Since neither patient had evidence of diffuse thoracic aortic atherosclerosis to limit longitudinal extent of spread, it is postulated that the intramural hematoma started at the level of the penetrating ulcer and extended into the ascending aorta in a retrograde fashion. This is a potentially lethal entity, not previously described, for which the optimal clinical management is unknown.

Objective: To determine if iron containing "siderotic" nodules detected at magnetic resonance (MR) imaging are regenerative (RN) or dysplastic (DN) and to attempt to identify features that may distinguish them., Material and Methods: MR imaging (1.5 T) was performed on 77 cirrhotic patients who underwent orthotopic liver transplantation within 0-117 days (mean 30 days) of MR imaging. Two readers retrospectively evaluated breath-hold gradient-echo pulse sequences (echo time > or =9.0 ms, flip angle < or =45 degrees) for the presence of hypointense nodules, which were classified as micronodular (< or =3 mm), macronodular (>3 mm), or mixed. Nodule distribution was classified as focal (<5), scattered (5-20), or diffuse (>20) per slice. Thin section pathologic correlation was available in all cases, and Prussian blue iron stains were performed., Results: Of 35 patients with pathologically proven siderotic nodules, 10 (29%) had at least 2 siderotic DN. MR detected siderotic nodules in 10 of 10 (100%) patients with siderotic DN and RN, and in 18 of 25 patients (72%) with siderotic RN only., Conclusion: Siderotic RN cannot be reliably distinguished from siderotic DN with MR imaging, and therefore the widely used term "siderotic regenerative nodule" should be avoided and replaced by "siderotic nodule."

Purpose: The purpose of this work was to determine the sensitivity of hepatic digital subtraction arteriography (DSA) for the detection of hepatocellular carcinoma (HCC) and dysplastic nodules (DNs) when compared with pathological findings from whole liver explants., Method: Twenty-one patients 30-72 years old (mean 54 years) with cirrhosis and known or clinically suspected HCC (20 prior to chemoembolization) underwent hepatic DSA with subsequent transplantation within 80 days (mean 32 days). The prospective DSA report was compared with pathologic findings from explanted livers., Results: Overall, DSA detected 31 of 95 HCC lesions for a sensitivity of 33%. Of these 31 lesions, 28 were hypervascular and 3 were hypovascular. DSA detected all six HCCs measuring >5 cm, all six HCCs measuring 3-5 cm, and all five HCCs 2-3 cm, resulting in a sensitivity of 100% (17/17) for HCC >2 cm. DSA detected 7 of 18 HCCs measuring 1-2 cm (sensitivity 39%) and 7 of 60 HCCs < or =1 cm (sensitivity 12%). Overall sensitivity for DSA in detection of HCC < or =2 cm was 18% (14/78 lesions). None of 17 DNs (0.2-1.5 cm in size) was identified on DSA., Conclusion: DSA is insensitive to small HCC (< or =2 cm), carcinomatosis arising within nodules, and DN.

Cirrhosis is a progressive, diffuse process of liver fibrosis that is characterized by architectural distortion and the development of a spectrum of nodules ranging from benign regenerative nodules to premalignant dysplastic nodules to overtly malignant hepatocellular carcinoma. The purpose of this essay is to demonstrate the ex vivo MR and pathology findings of these nodules as well as other masses that can be seen in the cirrhotic liver. The optimal conditions under which ex vivo imaging can be performed allow greater spatial resolution than that achieved with in vivo imaging, without artifacts that may degrade image quality. Clearly, contrast-enhanced MRI is essential for both the diagnosis and the characterization of focal lesions in the cirrhotic liver. However, the use of ex vivo imaging precludes the evaluation of these important in vivo pulse sequences.

Purpose: Our purpose was to determine the effects of apnea during end-inspiration compared with free breathing on timing examinations performed to optimize gadolinium-enhanced 3D MR angiography (MRA) of the thoracic aorta and arch vessels., Method: Thirty patients referred for gadolinium-enhanced 3D MRA of the thoracic aorta and branch vessels underwent two timing examinations: one performed during free breathing and one during apnea at end-inspiration to replicate more closely the respiratory pattern used to obtain 3D MRA. For each, axial images at the level of the proximal neck were acquired every 2 s for 40 s, during which time 1 ml of gadolinium contrast agent followed by 20 ml of saline was infused at 2 ml/s. The time to peak arterial enhancement (Ta), time to first jugular venous enhancement (Tj), and arterio-venous window (time from peak arterial enhancement to first jugular venous enhancement; AV) were compared for the two examinations in each patient., Results: Overall there was no statistically significant difference in Ta, Tj, or AV between examinations performed during free breathing and apnea in end-inspiration, although a trend to delayed circulation times was observed with apnea (p = 0.2-0.3). In five patients (17%), the difference in Ta between free breathing and apnea was 4 s; in three patients (10%), the difference was 6 s., Conclusion: Circulation times determined during apnea at end-inspiration may differ from those obtained during free breathing by as much as 6 s in an individual patient. This difference may account for inappropriately timed gadolinium-enhanced MR angiograms performed with timing examinations, especially when very short acquisition times and low doses of gadolinium (20 ml) are used.